Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
prolonging spray.
Popular Articles

More Intensive Glucose Control In Type 2 Diabetes Reduces Heart Attacks And Heart Disease Events
A meta-analysis of five trials has shown that more intensive glucose control in type 2 diabetes leads to fewer heart attacks and heart disease events - but has no significant effect on stroke or mortality from all causes. The findings are reported in an Article in this week"s diabetes special issue of The Lancet, written by Dr Kausik Ray, University of Cambridge, UK, and colleagues.
generic viagra
New "microcapsules" Put More Medication Into The Bloodstream To Treat Disease
Scientists are reporting a potential solution to a problem that limits the human body"s ability to absorb and use medications for heart disease, Type-2 diabetes, cancer and other conditions. It is a "nano-hybrid microcapsule" that enables the stomach to absorb more of these so-called "poorly-soluble" medicines. Their study is scheduled for the June 1 issue of ACS" Molecular Pharmaceutics, a bi-monthly journal.
Zubni implantati
News of the day
Sen. Grassley Pushes For Exclusion Of Abortion Coverage In Health Care Reform Legislation
Senate Finance Committee ranking member Chuck Grassley (R-Iowa) and committee Chair Max Baucus (D-Mont.) have been privately negotiating over how their panel"s version of health reform legislation will address abortion coverage, Newsweek reports. According to Newsweek, Grassley has been pushing to include measures that would prohibit what he considers "taxpayer-subsidized abortion."Earlier this month, NARAL Pro-Choice America, Raising Women"s Voices and other women"s health advocates intensified efforts to ensure that abortion access was treated like access to all other services in health care reform, according to Newsweek. The article points out, "Though usually publicly debated in the language of personal liberty and morality, abortion is a medical procedure performed by a doctor. It"s currently covered by most private insurance plans and existing government programs, at least under some circumstances. This expanded federal oversight and use of federal dollars raises several thorny issues." Grassley is urging that federally regulated and subsidized plans be prohibited from covering the procedure. Lawmakers also could weigh whether religious organizations -- such as Catholic hospitals or health plans -- could opt out of the coverage.Jill Kozeny, Grassley"s spokesperson, said the senator "is opposed to mandating abortion coverage in health care legislation." According to his office, "At one point during the recent negotiations, there was a (compromise) solution that didn"t work out." Grassley -- who is known as a staunch opponent of abortion rights -- said in March, "I take a view that there is almost anything compromisable in public affairs. Abortion is about the only issue I know of that"s not compromisable."Baucus" office declined to comment on the legislation, citing "longstanding Finance Committee policy not to discuss the specifics of ongoing negotiations." Erin Shields, Baucus" press secretary, noted that the lawmaker has a 100% approval rating from NARAL. She added, "He has always fought for a woman"s right to choose and will continue to do so."According to Newsweek, the House"s and the Senate Health, Education, Labor and Pensions Committee"s proposals do not specify covered benefits, instead leaving the decision to an independent commission or the HHS secretary. A recent National Women"s Law Center poll found that 62% of participants would oppose a provision excluding abortion and family planning coverage (Feder, Newsweek, 7/14).
Endocrinology

Nonin Medical Announces FDA Clearance For Its Next-Generation Regional Oximetry System

Nonin Medical, Inc., a leading innovator of noninvasive physiological monitoring solutions, announced FDA clearance for its Model 7600 Regional Oximetry System. Introduced in June 2009 at the European Society of Anaesthesiology (ESA) conference in Milan, Italy, the innovative Model 7600 offers real-time monitoring of cerebral oxygenation for patients at risk of ischemia. Utilizing next-generation near-infrared spectroscopy (NIRS) -- Nonin"s proprietary EQUANOX(TM) regional oximetry (rSO2) technology -- the Model 7600 measures oxygen saturation in the cerebral cortex. The innovative sensor design effectively removes surface tissue effects that can influence measurement accuracy -- isolating measurements of the cerebral cortex and providing rSO2 values. The Model 7600 offers industry-leading signal processing to enhance efficiency and an intuitive user interface with Bluetooth(R) wireless connectivity to streamline file access and storage. With over 20 years of signal processing and NIRS sensor design expertise, Nonin"s innovative technologies enable clinicians to accurately monitor a patient"s true condition in the most challenging environments. About Nonin Medical Inc Minneapolis-based Nonin Medical, Inc. is a privately owned company specializing in the design and manufacturing of noninvasive physiological monitoring solutions. Nonin distributes its products to health professionals in more than 125 countries and has over 100 OEM partners worldwide. Nonin"s industry-leading capabilities in signal processing and sensor design, plus its on-going integration of features not available in competitive products, are the foundation of its leadership in innovation. Nonin Medical, Inc


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009